Search research articles
Contact Us
Filters
Showing results (161-170 of 177) with videos related to
Page
of 18
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2018
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection
Sarah B Doernberg, Thuy Tien Tram Tran, Steven Y C Tong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 23, 2023
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Jessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 15, 2021
Antibacterial Resistance Leadership Group 2.0: Back to Business
Henry F Chambers, Scott R Evans, Robin Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 28, 2022
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials
Jessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
Journal of Clinical Microbiology
|
July 4, 2008
Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients
Tahaniyat Lalani, Jerome J Federspiel, Helen W Boucher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 11, 2019
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
Johann Motsch, Cláudia Murta de Oliveira, Viktor Stus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 14, 2020
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
Ivan Titov, Richard G Wunderink, Antoine Roquilly, et al.
The Lancet. Infectious Diseases
|
March 30, 2025
Intention-to-diagnose and distinct research foci in diagnostic accuracy studies
Scott R Evans, Gene Pennello, Shanshan Zhang, et al.
JAMA
|
April 4, 2013
Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial
Vance G Fowler, Keith B Allen, Edson D Moreira, et al.
The New England Journal of Medicine
|
September 27, 2023
Ceftobiprole for Treatment of Complicated <i>Staphylococcus aureus</i> Bacteremia
Thomas L Holland, Sara E Cosgrove, Sarah B Doernberg, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 177) with videos related to
Sort By:
Page
of 18
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2018
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection
Sarah B Doernberg, Thuy Tien Tram Tran, Steven Y C Tong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 23, 2023
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Jessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 15, 2021
Antibacterial Resistance Leadership Group 2.0: Back to Business
Henry F Chambers, Scott R Evans, Robin Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 28, 2022
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials
Jessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
Journal of Clinical Microbiology
|
July 4, 2008
Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients
Tahaniyat Lalani, Jerome J Federspiel, Helen W Boucher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 11, 2019
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
Johann Motsch, Cláudia Murta de Oliveira, Viktor Stus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 14, 2020
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
Ivan Titov, Richard G Wunderink, Antoine Roquilly, et al.
The Lancet. Infectious Diseases
|
March 30, 2025
Intention-to-diagnose and distinct research foci in diagnostic accuracy studies
Scott R Evans, Gene Pennello, Shanshan Zhang, et al.
JAMA
|
April 4, 2013
Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial
Vance G Fowler, Keith B Allen, Edson D Moreira, et al.
The New England Journal of Medicine
|
September 27, 2023
Ceftobiprole for Treatment of Complicated <i>Staphylococcus aureus</i> Bacteremia
Thomas L Holland, Sara E Cosgrove, Sarah B Doernberg, et al.
Page
of 18